Journal
TRENDS IN NEUROSCIENCES
Volume 39, Issue 3, Pages 146-157Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2016.01.008
Keywords
-
Categories
Funding
- Alzheimer's Research UK
- Parkinson's UK
- MRC
- MNDA
- BBSRC
- Wellcome Trust
- Rosetrees Trust
- BBSRC [BB/L019299/1] Funding Source: UKRI
- MRC [G0501573] Funding Source: UKRI
- Alzheimers Research UK [ARUK-PG2014-5, ARUK-EG2013B-1] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BB/L019299/1] Funding Source: researchfish
- Medical Research Council [G0501573] Funding Source: researchfish
- Parkinson's UK [G-1308] Funding Source: researchfish
- Rosetrees Trust [M451] Funding Source: researchfish
Ask authors/readers for more resources
Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis with associated frontotemporal dementia (ALS/FTD) are major neuro-degenerative diseases for which there are no cures. All are characterised by damage to several seemingly disparate cellular processes. The broad nature of this damage makes understanding pathogenic mechanisms and devising new treatments difficult. Can the different damaged functions be linked together in a common disease pathway and which damaged function should be targeted for therapy? Many functions damaged in neurodegenerative diseases are regulated by communications that mitochondria make with a specialised region of the endoplasmic reticulum (ER; mitochondria-associated ER membranes or 'MAM'). Moreover, several recent studies have shown that disturbances to ER-mitochondria contacts occur in neurodegenerative diseases. Here, we review these findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available